FDA Approves RHA Filler for Midface Contour Deficiencies
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
The approval covers cheek augmentation and age-related midface contour deficiencies, supported by phase III clinical trial data.
The trials will investigate whether rhPDGF-BB can improve infraorbital hollowing and stimulate collagen, elastin, and other changes in facial skin.